Curcumin vs. Placebo

A Phase 2, Double-blind, Randomized Study to Compare the Effect of Curcumin Versus Placebo on Inflammatory Cytokines, Symptoms and Disease Parameters in Clonal Cytopenia of Undetermined Significance (CCUS), Low-Risk Myelodysplastic Syndrome (LR-MDS), and Myeloproliferative Neoplasms (MPNs)

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
30 patients (estimated)
Sponsors
University of Southern California
Collaborators
National Cancer Institute (NCI)
Tags
Placebo, Randomization
Trial Type
Treatment
Last Update
4 weeks ago
SparkCures ID
1779
NCT Identifier
NCT06063486

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.